Sarms Lgd-4033 CAS 1165910-22-4

Cardarine, Gw 501516, CAS317318-70-0
Titanium Dioxide – Food Additive
LGD_4033_sarms

Sarms Lgd-4033 CAS 1165910-22-4

*Effects similar to anabolics with size and strength
*1Minimal Side Effects2 Excellent for recomping
*3Healing properties4 Prevents muscle wasting
*Works well as a stand alone or stacked with other SARMS

Categories: , Tags: , , , , , , , , , , , , , , ,
  • Description
  • Inquiry

Product Description

LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It’s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an route of administration.

Product Name:
LGD-4033
Synonyms:
4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile(LGD-4033);LGD-4033;4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile;4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile;LIGANDROL;4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile
CAS:
1165910-22-4

Function.

LGD4033 works by tying androgen receptors selectively. It shows anabolic activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called Phase I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo.






Related Products